PAI
AGN

Pittenger & Anderson Inc’s Allergan plc AGN Stock Holding History

Pittenger & Anderson Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100
Closed -$17K – 379
2019
Q2 		$17K Buy
+100
New +$13.8K ﹤0.01% 302
2018
Q1 		– Sell
-50
Closed -$8K – 404
2017
Q4 		$8K Sell
50
-6,650
-99% -$1.19M ﹤0.01% 362
2017
Q3 		$1.37M Sell
6,700
-240
-3% -$55.8K 0.12% 157
2017
Q2 		$1.69M Hold
6,940
– – 0.16% 136
2017
Q1 		$1.66M Sell
6,940
-500
-7% -$116K 0.17% 137
2016
Q4 		$1.56M Buy
7,440
+850
+13% +$176K 0.17% 136
2016
Q3 		$1.52M Sell
6,590
-2,685
-29% -$656K 0.17% 143
2016
Q2 		$2.14M Buy
9,275
+8,255
+809% +$1.9M 0.24% 108
2016
Q1 		$273K Sell
1,020
-75
-7% -$21.5K 0.03% 227
2015
Q4 		$342K Sell
1,095
-28
-2% -$8.34K 0.04% 221
2015
Q3 		$305K Sell
1,123
-1,550
-58% -$476K 0.04% 237
2015
Q2 		$811K Buy
2,673
+1,415
+112% +$422K 0.1% 177
2015
Q1 		$374K Buy
1,258
+28
+2% +$7.98K 0.05% 221
2014
Q4 		$317K Hold
1,230
– – 0.04% 220
2014
Q3 		$297K Sell
1,230
-165
-12% -$36.9K 0.04% 215
2014
Q2 		$311K Buy
+1,395
New +$289K 0.05% 223

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pittenger & Anderson Inc's AGN Position: Q3 2019 in Review

Pittenger & Anderson Inc sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 100 shares — an estimated $17K sold.

Pittenger & Anderson Inc first reported a position in AGN in Q2 2014 and held it in 16 quarters. The position peaked at $2.14M in Q2 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Pittenger & Anderson Inc reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 100 Allergan plc shares in Q3 2019, an estimated $17K.
  • Pittenger & Anderson Inc first reported a position in Allergan plc in Q2 2014 and held it in 16 quarters.
  • Pittenger & Anderson Inc's Allergan plc position peaked at $2.14M in Q2 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Pittenger & Anderson Inc's 13F filing for Q3 2019, filed 14 Nov 2019.